Investment Rating - The report maintains a "Buy" rating for the company [3][5]. Core Views - The company experienced a decline in revenue and net profit in 2025, with revenue at 5.824 billion yuan, down 9.74% year-over-year, and net profit attributable to shareholders at 798 million yuan, down 44.09% year-over-year [1]. - The gaming business faced pressure due to intensified global competition and the transitional phase of new projects, while software and IT services showed steady growth driven by AI, cloud, and IoT businesses [1][2]. - The company has a rich pipeline of new games, with two new titles, "Stellar Sanctuary" and "Next Agers," launched overseas and expected to contribute positively to revenue as they mature [3]. Financial Summary - Revenue projections for 2025-2027 are 5.824 billion yuan, 5.744 billion yuan, and 6.367 billion yuan, reflecting a year-over-year change of -9%, -1%, and +11% respectively [4]. - Net profit projections for the same period are 798 million yuan, 993 million yuan, and 1.076 billion yuan, with year-over-year changes of -44%, +24%, and +8% respectively [4]. - The company is currently in a low point due to existing product pressures and the incubation of new products, but there is optimism for a new growth curve as the product pipeline is released [3].

Investment Rating - The report maintains a "Buy" rating for the company [3][5]. Core Views - The company experienced a decline in revenue and net profit in 2025, with revenue at 5.824 billion yuan, down 9.74% year-over-year, and net profit attributable to shareholders at 798 million yuan, down 44.09% year-over-year [1]. - The gaming business faced pressure due to intensified global competition and the transitional phase of new projects, while software and IT services showed steady growth driven by AI, cloud, and IoT businesses [1][2]. - The company has a rich pipeline of new gaming products, with two new games, "Stellar Sanctuary" and "Next Agers," launched overseas and expected to contribute positively to revenue as they mature [3]. Financial Summary - Revenue projections for 2025-2027 are 5.824 billion yuan, 5.744 billion yuan, and 6.367 billion yuan, reflecting a year-over-year change of -9%, -1%, and +11% respectively [4]. - Net profit projections for the same period are 798 million yuan, 993 million yuan, and 1.076 billion yuan, with year-over-year changes of -44%, +24%, and +8% respectively [4]. - The company's earnings per share (EPS) for 2025 is projected at 0.41 yuan, with a price-to-earnings (P/E) ratio of 26.1x [4].

Core Viewpoint - Bernstein maintains an "outperform" rating for Xiaomi Group (1810.HK) due to its technology-driven premium strategy, strong overseas IoT business potential, and growth opportunities in electric vehicles in both China and international markets [1] Group 1: Investment Recommendation - Analysts note that Xiaomi's stock price has corrected approximately 28% from its peak since late September, suggesting that current valuation levels are attractive for long-term investors to buy [1]

Financial Data and Key Metrics Changes - Total revenues in Q3 2025 were $4.3 million, a decrease of 47.3% compared to Q2 2025, primarily due to the end of licensing revenues from Qualcomm [19] - Gross margin was 40.9% in Q3, down from 64.4% in Q2, reflecting a lower mix of high-margin licensing revenue [19] - Operating loss was $20.4 million in Q3, compared to an operating loss of $8.7 million in Q2 2025 [20] - Net loss for Q3 was $6.7 million, or $0.48 per diluted ADS, compared to a net loss of $9.1 million, or a loss of $3.59 per diluted ADS in Q2 2025 [21] - Cash and cash equivalents at September 30, 2025, totaled $13.4 million, down from $41.6 million at June 30, 2025 [21] Business Line Data and Key Metrics Changes - The IoT business pipeline remains healthy, representing about $550 million in potential three-year product revenue across 4G and RF product lines [10] - In Q3, the company won six new projects, with around $300 million of the pipeline being design win projects, a 20% increase from the last reported figure [10] - Q3 product revenue was impacted by minor delays, with expectations for Q4 product revenue to exceed $6 million [15] Market Data and Key Metrics Changes - The company holds 3,234 Bitcoin with a market value of $365.6 million, all pledged as security for $189 million of convertible debt issued in July [22] - Following a recent amendment of the debt agreement, 1,617 Bitcoin are being released from the pledge, and the company has sold 970 Bitcoin to reimburse half of the debt [22] Company Strategy and Development Direction - The company is committed to its Bitcoin treasury strategy and has proactively reduced its debt by 50% through a tactical sale of a portion of its Bitcoin holdings [5][6] - The goal is to unlock shareholder value and position the company better for future financing options, including preferred shares [7][9] - The IoT business is expected to grow and generate positive cash flow in 2026, with a potential 50% year-over-year growth into 2027 [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ramp-up of product revenue in Q4, despite challenges faced in Q3 [15][19] - The company aims to limit cash burn in 2026 to reach break-even by Q4, implementing a 20% cost reduction program across functions [18] - Management is exploring strategic alternatives for the IoT business to enhance overall value and cash flow generation [18] Other Important Information - The company is shifting from an opportunistic approach to a proactive go-to-market strategy for its IP portfolio, aiming to maximize customer reach and accelerate monetization [16] - The company has launched a new IP initiative and is in discussions for several licensing deals, with potential revenues from $3 million to $20 million [32] Q&A Session Summary Question: Were there any licensing or service revenues in Q3? - The revenue was about two-thirds product and one-third licensing and services in Q3 [26] Question: How aggressive will the company be on the buyback? - The company plans to be as aggressive as needed, considering the current stock price relative to net asset value [25] Question: What is the expected revenue for Q4? - The company is confident in achieving $7 million in revenue for Q4, based on backlog and secured orders [35] Question: What are the strategic alternatives being considered for the IoT business? - The company is exploring partnerships and other strategic options to enhance the value of its IoT business [18][33] Question: What is the timeline for the preferred shares issuance? - There is no specific timeline for issuing preferred shares, as it depends on negotiations and market conditions [45]

Investment Rating - The report maintains a "Recommended" rating for Haier Biomedical (688139) [1] Core Views - The company reported a 2.27% decline in revenue for H1 2025, totaling 1.196 billion yuan, and a 39.09% drop in net profit to 143 million yuan, primarily due to external factors and strategic investments [1][5] - New industries are showing growth, with their revenue share increasing to 47%, reflecting a 7.27% year-on-year growth, particularly in laboratory solutions and smart medication [5] - The overseas business is performing strongly, with a 30.17% increase in overseas revenue to 427 million yuan in H1 2025, while domestic revenue fell by 14.64% to 761 million yuan [5] Financial Summary - Total revenue projections for 2024A, 2025E, 2026E, and 2027E are 2,284 million, 2,630 million, 3,061 million, and 3,464 million yuan respectively, with expected growth rates of 0.1%, 15.2%, 16.4%, and 13.2% [1][6] - Net profit projections for the same years are 367 million, 423 million, 508 million, and 585 million yuan, with growth rates of -9.7%, 15.4%, 20.1%, and 15.1% [1][6] - The company’s earnings per share (EPS) is projected to increase from 1.15 yuan in 2024A to 1.84 yuan in 2027E [6]